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Abstract
Background: Clostridium bolteae and Clostridium clostridioforme, previously included in the complex C. clostridioforme
in the group Clostridium XIVa, remain difficult to distinguish by phenotypic methods. These bacteria, prevailing in
the human intestinal microbiota, are opportunistic pathogens with various drug susceptibility patterns. In order to
better characterize the two species and to obtain information on their antibiotic resistance genes, we analyzed the
genomes of six strains of C. bolteae and six strains of C. clostridioforme, isolated from human infection.
Results: The genome length of C. bolteae varied from 6159 to 6398 kb, and 5719 to 6059 CDSs were detected. The
genomes of C. clostridioforme were smaller, between 5467 and 5927 kb, and contained 5231 to 5916 CDSs. The two
species display different metabolic pathways. The genomes of C. bolteae contained lactose operons involving PTS
system and complex regulation, which contribute to phenotypic differentiation from C. clostridioforme. The Acetyl-CoA
pathway, similar to that of Faecalibacterium prausnitzii, a major butyrate producer in the human gut, was only found in
C. clostridioforme. The two species have also developed diverse flagella mobility systems contributing to gut colonization.
Their genomes harboured many CDSs involved in resistance to beta-lactams, glycopeptides, macrolides, chloramphenicol,
lincosamides, rifampin, linezolid, bacitracin, aminoglycosides and tetracyclines. Overall antimicrobial resistance genes were
similar within a species, but strain-specific resistance genes were found. We discovered a new group of genes coding for
rifampin resistance in C. bolteae. C. bolteae 90B3 was resistant to phenicols and linezolide in producing a 23S rRNA
methyltransferase. C. clostridioforme 90A8 contained the VanB-type Tn1549 operon conferring vancomycin resistance. We
also detected numerous genes encoding proteins related to efflux pump systems.
Conclusion: Genomic comparison of C. bolteae and C. clostridiofrome revealed functional differences in butyrate pathways
and in flagellar systems, which play a critical role within human microbiota. Most of the resistance genes detected in both
species were previously characterized in other bacterial species. A few of them were related to antibiotics inactive
against Clostridium spp. Some were part of mobile genetic elements suggesting that these commensals of the
human microbiota act as reservoir of antimicrobial resistances.
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Background
Clostridium bolteae and Clostridium clostridioforme are
members of the normal intestinal microbiota of humans,
which can cause intra-abdominal infections when the
natural intestinal barrier is altered. C. bolteae is present
in stools of most children, but counts are significantly
higher in autistic children than in controls [1]. Chronic
diarrheal episodes associated with some forms of autism
could be attributed to an overabundance of C. bolteae
and release of end products of metabolism, such as
butyrate, propionate and acetate, that alter the motility
and contraction rate of the gastrointestinal tract [2].
The two opportunistic pathogens have been isolated in
intra-abdominal infections, bacteremia and in abscesses
and various drug susceptibility patterns have been
reported [3]. Resistance to penicillin G is common but
only a few C. clostridioforme produce a beta-lactamase,
as detected by the nitrocefin test [4]. Most of the strains
are susceptible to ampicillin-sulbactam, piperacillin-
tazobactam, imipenem, and metronidazole. Resistance to
clindamycin and moxifloxacin was previously reported
in the complex C. clostridioforme [5]. In general, C.
bolteae appears more resistant than C. clostridioforme,
with higher MICs of penicillin G, ampicillin-sulbactam,
ticarcilllin, piperacillin and piperacillin-tazobactam and
more strains producing beta-lactamases [6]. Resistance
to aminopenicillins, lincosamides and quinolones has
been reported but not documented at genetic level.
Comparative analysis of 16S rRNA gene sequences of
clostridial strains place C. clostridioforme in the subcluster
XIVa of clostridia, including several non-spore-forming
cocci and mesophilic spore-forming rod shaped bacteria
[7]. C. bolteae was previously reported as a member of the
C. clostridioforme complex including C. clostridioforme
(formally), Clostridium aldenense, Clostridium citroniae
and Clostridium hathewayi [5, 6]. A divergence of 3 % in
16S rRNA separates C. bolteae from C. clostridioforme,
but few phenotypic characters distinguish the two species,
such as lactose fermentation, which is a key phenotypic
test [8] and little is known about their genetics.
Commensal anaerobes of gastrointestinal tract have
been proposed as reservoir for various antibiotic resist-
ance determinants [9]. However, the sequencing effort for
Clostridium spp., mainly concerns C. difficile a cause of
post-antibiotic diarrhoea. Only two genomes of C. bolteae
(strains BAA613 & WAL-14578) and three of C. clostri-
dioforme (strains 2149FAA.1, WAL-7855 and CM201.1)
are available in public databases.
The aim of this study was to analyse the genomes of six
clinical isolates of C. bolteae and six clinical isolates of C.
clostridioforme in order to identify genetic specificities
between these closely related species. We focused our
analysis on (CDSs coding for) functions, which could have
a physiological effect within microbiota, and provided the
catalogue of antimicrobial resistance genes of the two op-
portunistic pathogens.
Results and discussion
General features of genomes reveal intra and
interspecies variations
A total of 1 to 21 contigs were generated from assembly
of reads from Illumina (134 to 185-fold coverage) for the
six strains of C. bolteae (Table 1). A total of 10 to 48
contigs were generated (82 to 264-fold coverage) for the
six strains of C. clostridioforme. Total genome size varied
between species and strains. The size of C. bolteae
ranged from 6159 kb for strain 90A7 to 6480 kb for
strain 90B3 with 5833 and 6059 DNA-coding sequences
(CDSs), respectively, and four 16S rRNA genes. The
genome size of C. clostridioforme was smaller, from
5467 kb for strain 90A3 to 5970 kb for strain 90A6 with
5231 to 5916 CDSs, respectively, and four 16S rRNA
genes. The phylogenetic tree based on the 16S rRNA
sequences showed that the C. bolteae and C. clostridioforme
studied were closely related to C. hathewayi, C. aldenense,
C. citroniae, C. saccharolyticum and C. symbiosum, mem-
bers of the Clostridium cluster XIVa of Firmicutes, as
previously reported [6, 7] (data not shown).
Genomes of C. bolteae and C. clostridioforme are large
genomes, where genetic redundancy is prevalent (data
not shown). The redundant genes were involved in a
variety of metabolic pathways, including carbon metab-
olism, transport, iron metabolism and amino acid
biosynthesis. The differences in the number of CDSs
between genomes reflected variation in genetic redun-
dancy more than gain or loss of particular functions. In
addition, genomes integrated mobile elements i.e. trans-
posons, Insertion Sequences, plasmids or phages (integrase,
capsid protein,…) indicative of lateral gene transfers.
Some of them carried antimicrobial resistance genes
(see below).
To examine the pangenome of the two species, we
compared the 97,210 CDSs obtained from the 12 newly
sequenced genomes with those of five other genomes
(C. bolteae BAA613, C. bolteae WAL-14578, C. clostri-
dioforme CM201.1, C. clostridioforme 2149FAA.1, and
C. clostridioforme WAL-7855). All CDSs were clustered
using the BlastClust algorithm at high stringency, above
a 90 % sequence identity cut-off and 90 % length over-
lap. A total of 10,530 clusters were found. Only 2294
(21.78 %) clusters were shared by the two species.
In using only genomes newly sequenced, we esti-
mated the (species) core genome and (strain-specific)
genes of the six C. bolteae, and the six C. clostridio-
forme (Table 1). A total of 3714 genes formed the core
genome of C. bolteae. The number of strain-specific
genes in this species varied from 73 to 846. In C. clos-
tridioforme, 3660 genes defined the core genome. A
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C. bolteae 90A5 2009 perineal abcess 110254 176 12 6394 5833 5716 84 73
C. bolteae 90A7 2009 intraabdominal
fluid
110239 185 8 6159 5719 5592 743 735
C. bolteae 90A9 2009 douglas abcess 110242 134 1 6367 5833 5731 163 161
C. bolteae 90B3 2009 pelvis abcess 110247 176 4 6480 6059 5949 239 188
C. bolteae 90B7 2010 pleural abcess 110255 165 19 6398 5876 5761 120 105
C. bolteae 90B8 2010 ureteral abcess 110256 76 21 6449 6023 5901 905 846
C. clostridioforme 90A1 2009 intraabdominal
fluid
110245 145 16 5769 5669 5546 130 72
C. clostridioforme 90A3 2009 sigmoid abcess 110246 135 11 5467 5231 5096 31 21
C. clostridioforme 90A4 2009 bone biopsy 110238 264 48 5820 5726 5547 97 72
C. clostridioforme 90A6 2009 intraabdominal
fluid
110240 167 22 5970 5851 5711 307 273
C. clostridioforme 90A8 2009 intraabdominal
fluid
110249 82 47 5927 5916 5734 1190 1006














total of 2409 clusters were shared by the two species;
1305 genes were specific to C. bolteae and 1251 to C.
clostridioforme.
C. bolteae 90A7 and 90B8 had the largest number of
unique genes for this species (735 and 846, respectively).
C. clostridioforme 90A8, with 1006 (17 %) unique genes
had the largest number of strain specific genes in this
study. These strains integrated a high number of mobile
elements. Some unique CDSs were annotated as trans-
porters or regulators. Few of them were involved in
defence mechanisms (antimicrobial resistance genes..) or
metabolic pathways. Most of them, often surrounded by
CDSs from phages or transposons, were of unknown
functions (data not shown).
Functional differences between species in the
core genomes
The challenge of our study was to provide reliable informa-
tion from draft genomes. Therefore, we focused our ana-
lysis on the core genomes. The classification of the CDSs
according to the Clusters of Orthologous Groups (COGs)
system allowed to give an overview of the functions dis-
played by the two species. The core genomes of C. bolteae
and C. clostridioforme were enriched (over 7 % of total
COG matched counts) in COG categories K, E, G and R
relative to Transcription (309 and 290 CDSs), Amino acid
transport and metabolism (335 and 276 CDSs), Carbohy-
drate transport and metabolism (431 and 425 CDSs) and
General function prediction (366 and 331CDSs) (Table 2).











Total Number of Orthologs groups 3714 3660 2409 1305 1251
Ortholog groups in COGs 3060 2861 2151 909 710
No Hits on COGs 660 805 264 396 541
INFORMATION STORAGE AND PROCESSING
Translation, ribosomal structure and biogenesis (J) 151 148 137 14 11
Transcription (K) 309 290 191 118 99
Replication, recombination and repair (L) 111 135 85 26 50
CELLULAR PROCESSES AND SIGNALING
Cell cycle control, cell division, chromosome
partitioning (D)
43 43 36 7 7
Defense mechanisms (V) 84 72 52 32 20
Signal transduction mechanisms (T) 180 139 101 79 38
Cell wall/membrane/envelope biogenesis (M) 122 137 97 25 40
Cell motility (Cell motility and secretion) (N) 34 18 0 34 18
Intracellular trafficking, secretion, and vesicular
transport (U)
12 17 9 3 8
Posttranslational modification, protein turnover,
chaperones (O)
84 83 72 12 11
METABOLISM
Energy production and conversion (C) 194 155 120 74 35
Carbohydrate transport and metabolism (G) 431 425 296 135 129
Amino acid transport and metabolism (E) 335 276 238 97 38
Nucleotide transport and metabolism (F) 115 94 85 30 9
Coenzyme transport and metabolism (H) 99 89 72 27 17
Lipid transport and metabolism (I) 50 60 42 8 18
Inorganic ion transport and metabolism (P) 122 129 94 28 35
Secondary metabolites biosynthesis, transport
and catabolism (Q)
12 0 0 12 0
POORLY CHARACTERIZED
General function prediction only (R) 366 331 256 110 75
Function unknown (S) 187 178 150 37 28
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While C. bolteae and C. clostridioforme are phenotyp-
ically related, the pattern of functions obtained through
change in COG annotation differed between the two
species (Table 2). 30 additional CDSs of the Nucleotide
transport and metabolism (F), 97 CDSs of the Amino
acid transport and metabolism (E) and 79 CDSs coding
for Signal transduction mechanisms (T) categories were
specific for C. bolteae. 40 CDSs coding for the Cell wall/
membrane/envelope biogenesis (M), 50 CDSs for Repli-
cation, recombination and repair (L) and 18 CDSs for
the Lipid transport and metabolism (I) categories were
specific for C. clostridioforme. Differences between meta-
bolic pathways in C. clostridioforme and C. bolteae seem
to be large enough to support delineation of the species.
Among carbohydrate pathways, C. bolteae and C. clos-
tridioforme harboured different systems for the assimila-
tion of lactose, which differ in their phosphorylation
states, intermediate metabolites, and bioenergetics
(Additional file 1: Table S1). Genes coding for a β-
galactosidase, which hydrolyzes lactose yielding glucose and
galactose, were found in both species. An alternative lactose
catabolic pathway, the lactose/cellobiose dependent phos-
photransferase system (lac/cell-PTS) was found in almost
all genomes of C. bolteae. The lac/cell-PTS operon, previ-
ously described in C. acetobutylicum [10], consists of genes
for the 6-phospho-β-galactosidase, phosphoglycerate mu-
tase, and lichenan operon transcriptional antiterminator
and of two copies of genes for lactose/cellobiose family IIC,
IIB and IIA components. By such a system, lactose is phos-
phorylated at the C-6 carbon and the internalized lactose
6-phosphate is degraded in galactose 6-phosphate and
glucose by the 6-phospho-β-galactosidase. In addition, the
gene for the 6-phospho-β-galactosidase and the genes for
the lactose/cellobiose family components were lacking in C.
bolteae 90A7. It is likely that this system, inducible by
cellobiose or lactose and regulated by several repressors
(described in other Gram positive bacteria [11, 12]) ac-
counts for the lactose-negative phenotype in C. bolteae [6].
By using our annotation system, we detected a galactose
operon repressor (GalR) among lacI-family regulators, in C.
clostridioforme (all, except 90A8), but not in C. bolteae.
Laboratory experiments are needed to determine how the
transcription factors from the two species mediate prefer-
ences in the utilization of certain carbohydrates over others.
Other distinctive features between the two species
were CDSs coding for secondary metabolites biosyn-
thesis and transport and catabolism which were only
found in C. bolteae (Table 2).
Interestingly, the number of genes of the cell motility
and secretion category (N) (34 and 18 CDSs) was differ-
ent between the two species. Among them, we found
CDSs encoding flagella motility recognized as essential
virulence factors for most motile pathogens. Overall,
twenty-four genes (46 clusters + 3 orphans) represented
the flagellar operon in the genomes of C. bolteae.
Among them, genes for flagellin (fliC) and flagellar cap
(fliD), one of the multiple cell-surface adhesins of the
bacteria, revealed cluster specificity and microevolution.
Genes coding for fliD were represented by one cluster
and two additional genes in C. bolteae 90A7 and 90B8.
FliC sequences from C. bolteae 90A9, 90B3 and 90B8
formed one cluster, those from 90A5 and 90B7 clustered
in another group, and sequences from C. bolteae 90A7
remained orphans (unique genes) after clustering (Fig. 1).
They were closely related to flagellin sequences of C.
citroniae and C. hathewayi, other Clostridium spp. of
the group XIVa, isolated occasionally from human infec-
tions. In addition, C. bolteae 90A9 and 90B3 shared a
second operon of only 19 genes in syntheny, including a
flagellin gene (flaA) closely related to those of C. clostri-
dioforme (63 % identity). Based on conserved residues
L87, Q88, R89 and Q96 critical for TLR5 signalling and
flagellin polymerisation, these proteins were predicted to
have pro-inflammatory properties [13]. In C. clostridio-
forme, twenty genes (57 other clusters) organised in a
single operon encoded the flagellar apparatus. FlaA
sequences from C. clostridioforme belonged to a phylo-
genetic group closely related to flagellin sequences from
Eubacterium cellulosovens isolated from the rumen.
Overall, flagellin genes and loci organization related to
flagella were different between species (Additional file 2:
Table S2 and Additional file 3: Table S3), suggesting
that motility, chemotaxis, and occurrence of potential
interactions with the colonic mucosa are species
specific [14].
Species differences in pathways for butyrate synthesis
Comparison of whole genome sequences revealed that
pathways for butyrate synthesis, which play a key role in
colonic health in humans, were present in C. bolteae
and C. clostridioforme.
The two species were butyrate producers through dif-
ferent and complementary ways (Fig. 2, Additional file
4: Table S4). All C. clostridioforme, except 90A8, carried
a locus coding for the Acetyl-CoA pathway (from
Acetyl-CoA to butyryl-CoA), including genes for the
beta-hydroxylbutyrylCoA dehydrogenase (hbd), thiolase
(thl), crotonase (cro), butyryl-CoA dehydrogenase (bcd)
and two electron transfer proteins (ETF alpha, ETF
beta) (Additional file 4: Table S4). Only, C. bolteae
90A8 and C. clostridioforme 2149FAA.1 contained an-
other putative bcd (74.9 % identity) in their genomes
(data not shown). The locus composition and arrange-
ment were similar to that in Faecalibacterium prausnitzii,
a major butyrate producer of the human large intestine
[15]. The Acetyl-CoA pathway was not found in C. bolteae.
Both species shared genes for the two hydroxy-glutaryl-
CoA dehydrogenase (HgCoAd) and the glutaconyl-CoA
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decarboxylase (Gcd) from the Glutarate pathway that
can lead to crotonyl CoA and to butyryl-CoA via bcd
genes [16].
The final conversion from butyryl-CoA to butyrate
can be performed by the butyrate kinase (buk) and the
phosphotransbutyrylase (ptb) present in both species
(Additional file 4: Table S4). The group of buk sequences
from C. clostridioforme branched in the vicinity of the
buk sequence from C. citroniae on the phylogenetic tree
(Additional file 5: Figure S1). Buk sequences from C.
bolteae formed distinct monophyletic groups and
sequences distributed among the phylogenetic trees, sug-
gesting polymorphism and/or functional variations of
the enzyme in this species. Other genes for transferases
from the lysine pathway (ato—alpha and beta subunit ;
but—acetate CoA transferase), detected near the
butyrate locus in six genomes of C. clostridioforme,
can be involved as final enzymes. Genes from the
4-aminobutyrate pathway (4hbt) can be another alter-
native for the terminal step in C. bolteae 90A5, 90B7,
WAL14578, and BAA613 [16].
The butyryl-CoA:acetate CoA-transferase (but) of the
acetyl-CoA pathway, the final step in butyrate produc-
tion predominant in Clostridium XIVa, was neither
found in the common core genomes nor in the genomes
of the C. bolteae studied [17]. In the human gut, previ-
ous studies on colonic isolates of healthy individuals
have illustrated that but pathway predominates [18].
Further studies are needed to assess the impact of butyr-
ate production through the Glutarate pathway on health
of colonic cells, in particular in autism where C. bolteae
is overabundant [2].
Fig. 1 Distance-based phylogenetic tree of flagellin genes. Values at nodes corresponded to bootstrap percents obtained from phylogenetic trees
based on multiple sequence alignments by ClustalW, Tcoffee or Promals, respectively. Gene names and, orphan or cluster numbers were indicated
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Identification of antibiotic resistance determinants
Drug resistance genes that had not been recognized by
automated annotation were identified by homology
sequence research on ARDB. Resistance genes were pre-
dicted on a value up to 40 % identity (50 % of positive
substitutions) on 70 % of length above the cut-off value
usually recommended (see list in Table 3). Then, the
gene content and genetic organization of microbial
resistance loci of the six C. bolteae and the six C. clostri-
dioforme were compared to previous data obtained from
C. clostridioforme CM201.1 in our laboratory.
Because sequence-based predictions might potentially
identify determinants that do not lead to antimicrobial
resistance, susceptibility testing was performed to obtain
information on the predicted response of bacteria to
antibiotics. The strains included in this study showed
resistance patterns, including ampicillin, macrolides,
lincomycin and quinolones, now common in anaerobes
(Table 4). Both genomic data (CDSs and annotations)
and phenotypic susceptibility tests were considered to
identify antibiotic resistance determinants (Tables 3 and 4).
Preliminary assays for cloning certain genes were also
performed in order to check their capacity to confer anti-
biotic resistance (see below).
Genes of resistance to antibiotics used for treatment of
anaerobic infections
A total of 76 clusters and 21 strain-specific genes poten-
tially involved in antimicrobial resistance were identified
(Table 3). It’s included from 42 to 50 CDSs in C. bolteae
and 48 to 58 CDSs in C. clostridioforme. From 27 to 42
CDSs per genomes were related to drug resistance
mechanisms to beta-lactams, glycopeptides, macrolides,
lincosamides, and metronidazole.
Seven clusters involved in beta-lactam resistance are
shared or part of the core genome of the two species
(Fig. 3). Three types of beta-lactamases, including class
A beta-lactamase, class C beta-lactamase, class D [Oxa
type] beta-lactamase and several metallo-enzymes were
recognized in the twelve genomes. All the strains
studied, selected for their resistance to ampicillin, shared
the gene blaCLO1, previously found in C. clostridio-
forme CM201.1 (unpublished), but the structure of inte-
grative conjugative element (ICE) observed in CM201.1
Fig. 2 Different pathways for butyrate synthesis potentially present in genomes of C. clostridioforme and C. bolteae. In solid lines : found in C. bolteae and
C. clostridioforme; In bold dashed lines : only found in C. clostridioforme ; In fine dashed lines : only found in C. bolteae 90A5 and 90B7 (for more details, see
Additional file 4: Table S4). Genes (protein names) are displayed. Ato, Acetyl-CoA acetyltransferase ; Bcd, butyryl-CoA deshydrogenase ; Buk, butyrate kinase;
But, Butyrate-acetoacetate CoA-transferase ; Cro, crotonase ; Etf, electron transfer protein ; Gcd, glutaconyl-CoA decarboxylase ; Hbd, Acetoacetyl-CoA
reductase ; 4Hbt, 4-hydroxybutyrate CoA transferase ; HgCoAd, 3-hydroxybutyryl-CoA dehydrogenase ; Ptb, phosphate butyryltranferase; Thl, thiolase
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2 1 1 1 1 1 1 1 1 1 1 2 1
Teicoplanin,
Vancomycin
VanRA 4 2 1 1 1 1 3 1
VanSA 1 1 1 1 1 1 1
VanD 2 2 2 2 2 2
VanSD 1 1 1 1 1 1
VanXD 1 1 1 1 1 1
VanRD 2 1 1 1 1 1
Vancomycin VanHB 2 1 1 1 1 1 1 1 1 1 1 2 1







VanRE 1 1 1 1
VanG 1 1 1 1 1 1 1 1 1 1 1 1 1
VanRG 3 2 2 2 2 2 2 1 1 1 1 1 1
VanYG 1 1 1 1 1 1 1
VanUG 3 2 1
Teicoplanin VanZ 4 2 3 1 1 2 1 2 2 2 2 2 2
Lincomycin LnuA 3 1 1 1 1 1 1 1 1 1 2 1 2



















MacB 1 6 8 7 7 6 6 6 6 6 6 5 6
MefA 1 3 2 4 4 3 3 3 3 3 4 3 3
MsrA/MsrB 5 3 3 3 3 3
Lsa 1 1 1 1
ABC transporter
(efflux pumps)
VgaA 1 1 1 1 1 1 1 1 1 1 1 1 1
Tirc 1 1 1 1 1 1 1 1 1 1 1 1 1
CcmA 6 2 2 3 3 2 4 3
Streptogramin_A
Chloramphenicol
VatB 2 1 1 1 1 1 1 1 1 1 1 1 1
chloramphenicol CAT 3 1 1 2 1 1 1 1 1
linezolide Cfr 2 1 1 2 1 1 1 1 1 1 1
Rifampicin Arr 1 1 1 1 1 1 1
Metronidazole Nim 1 1 1 1 1 1 1 1 1 1 1 1 1
Trimethoprim Dfra20 1 1 1 1 1 1 1 1 1 1 1 1 1
Dfra 1 1
Aminoglycosides Aac6ie 2 2
Aad9ib 1 1
Ant6ia 3 1 1 2 1 2 1
Aph3iiia 1 2 1 1
Apha 3 3 3 3 3 3 3 3 3 3 3 3 3
Tetracycline Tet40 1 1 1
TetO 1 1 1 1 1 1 1 1
TetW 1 1 1 1 1
Tet32 1 1 1
Bacitracin BacA 3 1 1 2 2 1 1 1 2 2 1 1 2




















Table 4 Antibiogram of C. clostridioforme and C. bolteae
C. bolteae C. bolteae C. bolteae C. bolteae C. bolteae C. bolteae C. clostridioforme C. clostridioforme C. clostridioforme C. clostridioforme C. clostridioforme C. clostridioforme
Antimicrobial agent 90A5 90A7 90A9 90B3 90B7 90B8 90A1 90A3 90A4 90A6 90A8 90B1
Beta - lactams
ampicillin R R R R R R R R R R R R
amox-clavulanic acid S S S S S S S S S S S S
cefoxitin S S S S S S S R S I S I
imipenem S S S S S S S S S S S S
Glycopeptides
Vancomycin S S S S S S S S S S Ra S
Macrolides
Erythromycin R R I R R R R R R R R R
Telithromycin (Ketolides) R R S R R R R R R R R R
Spiramycin S S S R S I S S R R R S
Lincosamides
Lincomycin I R R R R R S I R R R R
Clindamycin S S S R S S S S R S R S
Streptogramins
Pristinamycin S S S nd I S S S S S S S
Amphenicols
Chloramphenicol nd S S R S R S S S S S S
Oxazolidinones
Linezolid S S S Rb S S S S S S S S
Rifampin S Rc S S S S S S S S S S
Quinolones
Ciprofloxacin R R R R R R R R R R R R
Moxifloxacin R R R R R R R R R R R R
Tetracyclines
Doxycycline S R R R R S R R R R R R
Nitroimidazole
Metronidazole S S S S S S S S S S S S
Polypeptides
Colistin R R R R R R R R R R R R
aMIC vancomycin > 250 mg/l
bMIC linezolid =16 mg/l














was not found in the new genomes sequenced. The gene
blaCLO1 confers resistance to aminopenicillins and
carboxypenicillins in E. coli, and its activity is inhibited
by clavulanate and sulbactam. Nine amino acid changes
were observed in beta-lactamases of C. bolteae 90A9,
90B3 and 90A8. This closely related beta-lactamase was
flanked by insertion sequences (IS66) and a putative
gene for class D beta-lactamase (COG 2602) also
described in Clostridium sp M62/1 from the human
intestinal microflora (HMP project). Genes for class C
beta-lactamases, previously found in the chromosomes
of enteric bacteria (COG2680), were also present in C.
bolteae and C. clostridioforme.
A high number of predicted genes (32 CDSs) were
involved in resistance to glycopeptides (Additional file 6:
Figure S2). C. clostridioforme 90A8 was the single strain
with all genes required for glycopeptide resistance in agree-
ment with the phenotype (MIC > 256 mg/l). Vancomycin
resistance in this strain was attributed to a VanB-type op-
eron borne by a Tn1549-like element. Unfortunately, a dele-
tion of ten nucleotides within the relaxase gene of Tn1549
leads to the inability of 90A8 to transfer vancomycin resist-
ance in vitro [19]. The other genomes of C. clostridioforme
included part of the VanD-type vancomycin resistance
operon, but the D-Ala-Lac ligase vanD gene was disrupted
by a stop codon leading to a truncated protein (Additional
file 6: Figure S2). In addition vanH and vanY, which encode
a D-lactate dehydrogenase and a DD carboxypeptidase,
respectively, were missing. Similarly, the genomes of C.
bolteae harboured four CDSs, homolog of vanRGvanUG-
vanG vanYG, which formed an incomplete and non-
functional operon due to the lack of a serine racemase
gene. The high number of CDSs coding for glycopeptide re-
sistance (including vanD or vanG known to be chromo-
somal and not transferable) found in the genomes of C.
bolteae and C. clostridioforme, suggests that they are part of
ancestral entire operons, which have evolved in the ab-
sence of antibiotic selective pressure [20]. Presence of
incomplete van operon is intriguing, but similar ob-
servations in other anaerobes living in microbiomes
such as Clostridium difficile 630 or Ruminococcus spp.,
have been reported [21, 22].
Homologues to the adenylyltransferase [lnuA] gene
conferring resistance to the lincosamides, were present
in the core genome of both species (Fig. 3). LnuA genes
of C. clostridioforme and C. bolteae had 70 to 72 %
identity with orthologs found in C. hathewayi and C.
citroniae, respectively. C. clostridioforme 90B1 and 90A6
Fig. 3 Distribution of antibiotic resistance genes shared between and within the core of C. bolteae and C. clostridioforme. Genes overlapping at least 90 %
length and 90 % of similarity were considered homologs. Resistance genes were predicted on a value up to 40 % identity (50 % of positive substitutions)
on 70 % of length by homology sequence research on ARDB. For all C. clostridioforme and some C. bolteae 23S rRNA methyltransferase Cfr-like
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harboured an additional lnu gene (68 % identity with
LnuA90A5), with no traces of mobile elements. Lincomycin
resistance is common in C. bolteae and C. clostridioforme,
often associated with resistance to clindamycin. LnuA
proteins of the two species displayed 51 to 54 % of identity
with LnuA from Staphylococcus suggesting common func-
tionality, but the role of lnu genes is difficult to establish
due to the presence of other putative mechanisms [23].
Similarly, all strains were resistant to erythromycin,
whereas two genes homolog to the erythromycin ribo-
some methylase gene, ermB, were only predicted in the
genomes of C. clostridioforme 90A4 and 90A8. Over-
expression of multidrug efflux pumps and Macrolide-, and
various Macrolide-Lincosamide-Streptogramin B—specific
efflux systems, such as MacB, MefA, VgaA, MsrA/MsrB,
and CcmA (Table 3, Additional file 7: Figure S3), found in
the genomes studied, can lead to macrolide and lincosa-
mide resistance [24]. In addition, two clusters of CDSs
coding for xenobiotic acetyltransferases related to VatB
(48 % identity) were found in the core genomes of each of
the species (Fig. 3). VatB inactivates virginiamycin [25],
but here, the resistance was not detected by anti-microbial
susceptibility tests (Table 4).
A cluster of CDSs homologues to the metronidazole
resistance (nim) genes was detected in the core genomes
of both species, and metronidazole was very active on
the species studied [26]. In Bacteroides fragilis it has
been demonstrated that increased expression of nim genes
when downstream from IS elements leads to metronida-
zole resistance [27]. In the lack of IS directly upstream the
nim genes, the mechanism to confer metronidazole resist-
ance to C. bolteae and C. clostridioforme remains to be
established.
Unexpected observation of new genes of resistance
Regarding other drug resistances, genome data revealed
genes related to chloramphenicol and rifampin resist-
ance mechanisms (Table 3). In most genomes of each
species, we found CDSs coding for a group A chloram-
phenicol acetyltransferase [cat] which can inactivate
chloramphenicol. However, only C. bolteae 90B3 and
90B8 were resistant to chloramphenicol. The genome of
strain 90B8 contained a second copy of the cat gene
borne by a Tn4451-like transposon (96 and 90 % identity
with Tn4451 and Tn4453, respectively). The 90B3
genome contained a CDS homolog to the gene cfr
coding for a 23S rRNA methyl-transferase largely spread
in Gram-positive bacteria. As expected, the strain 90B3
was also resistant to florfenicol, tiamulin, and linezolid
(MIC = 16 mg/l). Other 23S rRNA methyltransferase
(Cfr-like) CDSs were detected in an environment rich in
transposable elements (Tn 6103-6110-CTn4 [fragments])
in the genomes of C. clostridioforme and C. bolteae 90A5
and 90B7, but the rRNA methylation did not appear to
affect the susceptibility to chloramphenicol (Fig. 3).
The analysis of genomic data allowed to recognize
CDSs homologues to rifampin-ADP-ribosyltransferase
(arr) genes in C. bolteae but not in C. clostridioforme.
No mobile elements or traces of mobile elements were
found around the arr genes suggesting they were
indigenous to this species. This new Arr sequences
branched in the vicinity of Arr proteins from C. sacchar-
operbutylacetonicum and some Cyanobacteria on the
phylogenetic tree (Additional file 8: Figure S4). They
were distinct from Arr-2 proteins of Enterobacteriaceae
and from Arr proteins of Mycobacterium and Streptomyces
spp.. All strains, except 90A7, were susceptible to rifampin.
In the absence of mutations in rpoB (known to be respon-
sible for rifampin resistance), resistance of C. bolteae 90A7
(MIC: 32 mg/l) was likely due to positive selection of muta-
tions in aarCbol90A7. Susceptibility to rifampin of other C.
bolteae was likely due to the lack of promoters upstream
from arr (as predicted by in silico analysis) or to nucleotide
substitutions within arr leading to amino acid replacement
and functional inactivation (data not shown).
Concerning the resistance of all strains against moxi-
floxacin and ciprofloxacin, all strains of C. bolteae
showed several substitutions in the “quinolone-resist-
ance–determining region” (QRDR) of gyrB. We didn’t
find any substitutions in this region for gyrA, nor
described in the protein of the quinolone-resistant
epidemic strain, C. difficile 027 [28]. Therefore, GyrB
was likely the preferred target in acquisition of quin-
olone resistance in these two species. In addition, several
CDSs coding for AcrB inner membrane transporter were
present in all the strains. These transporters are part of
a resistance-nodulation-division [RND] multidrug efflux
pump, known to increase efflux of quinolones in some
Gram-negative bacteria [29]. Further studies are needed
to determine their influence in the loss of susceptibility
of Clostridium spp. to fluoroquinolones.
Overall, similar resistance profiles against antibiotics
in C. bolteae and C. clostridioforme can result from vari-
ous mechanisms.
Genes of resistance to antibiotics less active or inactive
against Clostridium spp
The genomes of C. bolteae and C.clostridioforme carried
one or two copies of the undecaprenyl pyrophosphate
phosphatase gene bacA, and 2 to 5 copies of the efflux
pump genes, bcrA, involved in bacitracin resistance, in
agreement with their low susceptibility [26]. We also
found one cluster of CDSs homolog to the dihydrofolate
reductase gene, dfrA20 (41 % identity / 97 % length) of
Pasteurella multocida in the core genome of both
species that could explain the poor activity of trimetho-
prim on our Clostridium spp. [30]. In addition, C.
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clostridioforme 90A6 harbored a CDS identical to dfrA
from Enterococcus faecium. This gene detected in an
environment rich in mobile elements is consistent with
a new example of horizontal transfer between Enterococcus
spp. and Clostridiales.
Interestingly, the genomes of C. bolteae or C. clostri-
dioforme contained various resistance genes against
antibiotics naturally inactive on these species. Five CDSs
were homologs of genes that phosphorylate, acetylate or
adenylylate aminoglycosides. Four of these putative
resistance genes were detected in an environment of mo-
bile elements. Three genes, aadE, sat4 and aph(3’)-III,
conferring resistance to streptothricin, streptomycin and
kanamycin, respectively, was found part of a transposon
delineated by two IS1182 copies in C. clostridioforme
90A3 (two copies), 90A6 and 90B1. The aph(3’)-III
detected was identical to the aph(3’)-III, part of the multi-
drug resistant plasmid PF856 from E. faecium [31], also
related to an internal domain (99 % identity) of a SSCmec
element of Staphylococcus aureus HT20040085. Similarly,
the aminoglycoside 6-adenylyltransferase gene ant(6’)-Ia,
conferring resistance to streptomycin was shared by
C. clostridioforme 90A1, 90A3 (2 copies), 90A4, 90A6
(2 copies) and C. bolteae 90A7. The adenylyltransferase
gene aad(9’)-b which mediates resistance to streptomycin/
spectinomycin was found in C. bolteae 90B3. Two copies
of the acetyl transferase aac(6’)-Im were also present in
the genome of C. clostridioforme 90B1. Homologs of
AAC(6’)-Im which confers resistance to tobramycin and
amikacin resistance was also found in E. coli (96 %
identity), Coprococcus sp, C. difficile and Enterococcus
faecium (data not shown). In addition, three CDSs coding
for an aminoglycoside kinase (APH), known to be widely
distributed in Gram-positive bacteria, were also observed
among all the strains [32].
Numerous tetracycline resistance genes were also de-
tected in C. bolteae and C. clostridioforme. They include
both efflux genes such as tet40, and ribosome protection
determinants such as tetO, tetW, and tet32, previously
reported as circulating in gut microflora among distantly
related bacteria [33].
Conclusion
We studied the genomes of C. bolteae and C. clostridio-
forme, two species of the complex Clostridioforme, which
can behave either as members of the human microbiota
or as opportunistic pathogens.
We compared the genomes of six clinical isolates of C.
bolteae and 6 strains of C. clostridioforme with available
genome sequences in laboratory and international
databanks. These data were used as a basis to reveal
differences in functional patterns between the two
species. Among them, differences in flagella coding
genes and butyrate pathways can potentially influence
host-gut microbiota interactions.
The patterns of resistance genes in the genomes were
also of peculiar interest: (i) these bacterial species
harbour specific and indigenous putative resistance
genes, which included ABC transporters, antibiotic
modifying enzymes, rRNA methyltransferases, (ii) Other
resistance genes were acquired as shown by their
location within mobile elements in the genomes studied.
Some of them corresponded to genes mainly spread in
gut bacteria. Others were new determinants, which re-
main to be analysed for their ability to confer antibiotic
resistance. This study emphasizes the role of commensal
bacteria of the digestive microbiota as reservoir for anti-
biotic resistances.
Future directions
As the costs of whole-genome sequencing continue to
decline, it becomes increasingly available in routine diag-
nostic laboratories to detect antimicrobial resistance
genes in genomes as substitute of traditional methods
for resistance identification. However, the true challenge
will remain to extract the relevant information from the
large amount of data and to ensure the functionality of
the genes detected.
Methods
Bacterial strains, molecular Identification and
antimicrobial susceptibility testing
We studied retrospectively 6 strains of C. bolteae and 6
strains of C. clostridioforme, resistant to beta-lactams.
Strains were isolated from intra-abdominal infections
from patients (without links) over 2 years in two hospi-
tals, Paris Saint Joseph and CHRU of Nancy, France.
Clostridium isolates were grown in Brain Heart Infusion
agar or broth (Oxoid) in an anaerobic atmosphere (5 %
CO2, 5 % H2 and 90 % N2) at 37 °C. Antibiotic susceptibility
was tested by disk diffusion on Mueller-Hinton (MH)
medium supplemented with 5 % defibrillated horse
blood, according to the standards of the Comité de
l’Antibiogramme de la Société Française de Microbiologie
(http://www.sfm-microbiologie.org/). MICs of antimicrobial
agents were determined on MH agar by Etest (bioMérieux).
Genomic DNA for sequencing was prepared from cells
by lysis in lysozyme, incubation in proteinase K/SDS,
followed by a standard phenol/chloroform extraction
procedure. Prior to library preparation DNA quality was
assessed by Nanodrop analysis (Thermo Scientific).
Molecular identification of strains was performed by
sequencing a 1483-bp PCR fragment from 16S rRNA using
universal primers B27F (5’-AGAGTTTGATCCTGGCT
CAG) and U1492R (5’-GGTTACCTTGTTACGACTT)
[34]. The taxonomic assignment of sequences was checked
on the RDP classifier of the Ribosomal Database Project
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v11.1 [35]. Closely related 16S rRNA sequences found in
the database were aligned with the newly determined
sequences and a phylogenetic tree was re-constructed
according to the neighbor-joining method of the Phylip
package [36]. The stability of the groupings was estimated
by bootstrap analysis (100 replications). The identification
of C. bolteae 90A7, previously misnamed C. clostridioforme
90A7, was corrected (see Results and discussion).
Whole genome sequencing
This sequencing project was part of the Human
Microbiome U54 initiative of the Broad Institute
(broadinstitute.org). For each genome, paired end libraries
were generated using Illumina’s Phusion-based library kits
following the manufacturer’s protocols (Illumina, Hayward,
CA, USA). Samples were multiplexed and sequenced on
Illumina GAIIx machines and base-called following the
manufacturer’s protocols. Individual samples of paired
90 nt reads generated 76 to 185-fold coverage of the
genomes of C. bolteae (~6.37 Mb) and 82 to 264-fold
coverage of the genomes of C. clostridioforme (~5.75 Mb),
respectively (Table 1). Sequences were de novo assembled,
yielding 1 to 21 contigs for genomes of C. bolteae and 10 to
48 contigs for those of C. clostridioforme.
Accession to our set of genomic sequences of Clostridium
spp in public databases
All the genomes sequenced are available on the Broad
Institute website (http://www.broadinstitute.org/data-soft-
ware-and-tools) (Genbank Bioprojects : PRJNA64845,
PRJNA64847, PRJNA64849, PRJNA64851, PRJNA64853,
PRJNA64857, PRJNA659, PRJNA64861, PRJNA64863,
PRJNA64865, PRJNA64867, PRJNA64869). The genomes
of C. beijerinckii NCIMB 8052 (Clostridium sensu stricto),
C. saccharolyticum WM1, C. bolteae BAA613 were re-
trieved from the PATRIC website (Genbank acc number:
CP000721, CP002109; Bioproject: PRJNA18165). The
genomes of Clostridium butyricum 60E.3.1, Clostridium
colicanis 209318 (Clostridium sensu stricto), Clostridium
bolteae WAL-14578, C. clostridioforme CM201.1, Clostrid-
ium clostridioforme 2149FAA.1, C. clostridioforme WAL-
7855 (Clostridium cluster XIVa) and, C. innocuum
6_1_30.1 (Clostridium cluster XVIII) were selected from
the Broad Institute (Genbank Bioprojects: PRJNA64855,
PRJNA64873, PRJNA46383, PRJNA64871, PRJNA46389,
PRJNA46391, PRJNA39359, respectively).
Annotation of genome sequences and ortholog groups
Automated genome annotation was generated at the
Broad Institute. Additional information was obtained
through a proteome analysis pipeline including protein
domains search by RPS-Blast with the NCBI Conserved
Domain Database [37] and, manual annotation. To
improve annotation of the genomes, we determined
ortholog groups accross our dataset by using the single-
linkage algorithm of BlastClust (NCBI Blast package) at
a high stringency level (S90-L0.9). If necessary, a protein
sequence was (re)annotated with the ortholog group
whose average Blast similarity was highest. In addition,
CDSs named according to their position on contigs
(ordered locus number) allowed to identify conserved
synteny between genomes. Annotation of clusters was
also conducted by homology search against the Clusters
of Orthologous Groups (COG) protein database [38].
Detection of putative resistance genes
Antibiotic resistance genes were searched for by using
BLASTp at various stringency levels against the Antibiotic
Resistance Genes Database (ARDB) on a local machine
[39]. Manual sorting of similarities and positive matches
of the predicted protein sequences permitted to select
manually the closely related AR proteins, and to assign
functional annotation.
Putative extrachromosomal elements (e.g., ICEs or
Transposons) were detected in the genomes of C. clostri-
dioforme and C. bolteae by using BLASTp through the
ICEberg database [40] upgraded with a personal
collection of mobile elements from Firmicutes. A visual
inspection of microsynteny (small scale of synteny) was
also performed in regions surrounding resistance genes
in order to detect mobile elements (e.g. transposase
encoding genes) or their traces.
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